| Project Title | Actemra (Tocilizumab) Utilization Among Pregnant Women |
| Date Posted | Tuesday, July 18, 2017 |
| Project ID | cder_mpl1r_wp049_nsdp_v01 |
| Status | Complete |
| Deliverables | |
| Description | This report contains estimates of tocilizumab use that occurred during a pregnancy resulting in a liveborn delivery, or within 90 days prior to the estimated start of pregnancy. This query request was distributed to 16 Data Partners on February 9, 2017, and requested data that spanned from the time period of January 1, 2010 to Septemeber 30, 2015. |
| Medical Product | Actemra tocilizumab |
| Health Outcome | juvenile rheumatoid arthritis rheumatoid arthritis |
| Population / Cohort | All females 15 - 54 years of age with a live birth between January 2010 - December 2015 |
| Time Period | 2010 - 2015 |
| Assessment Type | Exploratory Analyses |
| Study Type | Modular Program |
| FDA Center | CDER |
